AMYLIN PHARMACEUTICALS INC: cashflow_operating
| Value | {"amount": -19510000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2008-01-01 – 2008-12-31 |
| Status | current |
| Entity | AMYLIN PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:48:00.440667+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/aaecf7db-b359-4edd-9af6-3e43f0003899
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-11-001418 · Open the official SEC filing →Retrieved: 2026-08-19T08:48:00.440667+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000881464/cashflow-operating/2008-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/aaecf7db-b359-4edd-9af6-3e43f0003899
History
- no predecessors — first report